AUSF - ETF AI Analysis
Top Page
Global X Adaptive U.S. Factor ETF (AUSF)
AUSF, the Global X Adaptive U.S. Factor ETF, earns a solid overall rating thanks to several high-quality holdings like Microsoft, Apple, Verizon, and Cisco, which combine strong financial performance with growth in areas such as cloud, AI, and services and generally supportive technical trends. The fund’s score is tempered by weaker names like Verisign, Berkshire Hathaway B, and TXNM Energy, where bearish momentum, overvaluation, and profitability or cash flow concerns introduce more risk. The main risk factor is that some holdings show signs of being overvalued or technically overbought, which could lead to more volatility if market conditions worsen.
AUSF vs. SPDR S&P 500 ETF (SPY)
- AUM
- 902.41M
- Region
- North America
- Expense Ratio
- 0.27%
- Beta
- 0.50
- Issuer
- Global X
- Inception Date
- Aug 24, 2018
- Dividend Yield
- 2.65%
- Asset Class
- Equity
- Index Tracked
- Adaptive Wealth Strategies U.S. Factor Index (USD)
AUSF Summary
AUSF is the Global X Adaptive U.S. Factor ETF, which follows the Adaptive Wealth Strategies U.S. Factor Index. It invests across the whole U.S. stock market, from large to small companies, and spreads money over many sectors like technology, health care, and financials. Well-known holdings include Microsoft, Apple, Verizon, and Johnson & Johnson. Someone might invest in AUSF for broad diversification and the potential for growth, since it adjusts its mix of stocks based on changing market conditions. A key risk is that it still moves up and down with the overall U.S. stock market, so your investment value can fluctuate.
How much will it cost me?
This ETF has an expense ratio of 0.27%, which means you’ll pay about $2.70 per year for every $1,000 invested. That’s a bit higher than the average low-cost index ETF because this fund uses an adaptive, actively managed factor strategy rather than simple passive tracking.
What would affect this ETF?
Because AUSF invests broadly in U.S. stocks and leans into factors like value and momentum, it could benefit if the U.S. economy grows steadily, interest rates stabilize or fall, and large financial, technology, and health care companies such as Microsoft, Apple, and Johnson & Johnson perform well. On the downside, a U.S. recession, rising interest rates, or sector-specific problems in areas like financials or communication services (including major holdings like Verizon and AT&T), as well as changes in market behavior that reduce the effectiveness of its factor strategy, could hurt future returns.
AUSF Top 10 Holdings
AUSF is leaning into a mix of Big Tech and defensive stalwarts, with Microsoft and Apple doing much of the heavy lifting as their cloud, AI, and iPhone ecosystems keep the fund’s tech sleeve rising. Health care names like Johnson & Johnson and Royalty Pharma add a steady, almost bond-like ballast, with Royalty Pharma quietly powering ahead. On the flip side, old-school telecoms Verizon and AT&T are losing steam, and Berkshire Hathaway has been more of a quiet passenger than a driver. Overall, it’s a U.S.-only portfolio blending growth engines with income-oriented laggards.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 VZ | Verizon | 1.95% | $17.54M | $185.39B | 14.81% | 81Outperform |
 MSFT | Microsoft | 1.87% | $16.83M | $3.88T | -0.73% | 79Outperform |
 MSI | Motorola Solutions | 1.70% | $15.27M | $81.35B | 13.79% | 70Neutral |
 T | AT&T | 1.68% | $15.13M | $144.23B | -13.25% | 71Outperform |
 BRK.B | Berkshire Hathaway B | 1.64% | $14.77M | $1.16T | 13.37% | 66Neutral |
 RPRX | Royalty Pharma | 1.65% | $14.87M | $38.72B | 81.86% | 79Outperform |
 LMT | Lockheed Martin | 1.65% | $14.86M | $147.14B | 30.06% | 70Outperform |
 VRSN | Verisign | 1.60% | $14.44M | $27.56B | 30.39% | 62Neutral |
 JNJ | Johnson & Johnson | 1.60% | $14.38M | $657.68B | 44.51% | 78Outperform |
 CME | CME Group | 1.58% | $14.22M | $108.50B | 15.31% | 74Outperform |
AUSF Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For AUSF, the sentiment is Positive. The current price of 51.89 is above the 20-day moving average (MA) of 50.38, above the 50-day MA of 50.67, and above the 200-day MA of 49.43, indicating a bullish trend. The MACD of 0.42 indicates Negative momentum. The RSI at 64.41 is Neutral, neither overbought nor oversold. The STOCH value of 76.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AUSF.
AUSF Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| AUSF | $51.89 | $56.00(7.92% Upside) | $902.41M | 0.27% | 71Outperform |
 HLAL | $71.52 | $93.09(30.15% Upside) | $972.36M | 0.50% | 76Outperform |
 SEUS | $25.65 | $31.01(20.90% Upside) | $946.37M | 0.30% | 73Outperform |
 BGDV | $31.27 | $37.04(18.46% Upside) | $877.55M | 0.45% | 74Outperform |
 AAUB | $49.94 | $61.40(22.95% Upside) | $845.51M | 0.10% | 66Neutral |
 FDMO | $89.89 | $116.74(29.86% Upside) | $842.60M | 0.15% | 73Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AUSF | Global X Adaptive U.S. Factor ETF | 51.89 | 8.18 | 18.72% | |
| HLAL | Wahed FTSE USA Shariah ETF | 71.52 | 11.05 | 18.27% | |
| SEUS | SEI QiM U.S. Equity Factor Allocation Active ETF | 25.65 | 0.39 | 1.53% | |
| BGDV | Bahl & Gaynor Dividend ETF | 31.27 | 5.13 | 19.62% | |
| AAUB | Alpha Architect US Equity 4 ETF | 49.94 | 0.45 | 0.91% | |
| FDMO | Fidelity Momentum Factor ETF | 89.89 | 6.69 | 8.04% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.